Axsome Therapeutics

(NASDAQ) AXSM

Current Price$224.03

Market Cap$11.14B

Since IPO (2015)+2,377%

5 Year+280%

1 Year+101%

1 Month+22%

Axsome Therapeutics Financials at a Glance

Market Cap

$11.14B

Revenue (TTM)

$708.24M

Net Income (TTM)

$188.30M

EPS (TTM)

$-3.74

P/E Ratio

-57.89

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$224.03

Volume

633,303.653

Open

$217.34

Price

$224.03

Volume

633,303.653

Open

$217.34

Previous Close

$224.03

Daily Range

$214.31 - $224.75

52-Week Range

$96.09 - $234.29

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$224.03

Volume

633,303.653

Open

$217.34

Previous Close

$224.03

Daily Range

$214.31 - $224.75

52-Week Range

$96.09 - $234.29

AXSM News

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain

Jonathan PoncianoMar 18, 2026

Page 1

AXSM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Axsome Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,220

CEO

Herriott Tabuteau, MD

Website

www.axsome.com

Headquarters

New York City, NY 10007, US

AXSM Financials

Key Financial Metrics (TTM)

Gross Margin

93%

Operating Margin

-25%

Net Income Margin

-27%

Return on Equity

-349%

Return on Capital

-64%

Return on Assets

-26%

Earnings Yield

-1.73%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.14B

Shares Outstanding

51.46M

Volume

633.30K

Avg. Volume

700.77K

Financials (TTM)

Gross Profit

$591.02M

Operating Income

$169.24M

EBITDA

$168.08M

Operating Cash Flow

$93.41M

Capital Expenditure

$480.00K

Free Cash Flow

$93.89M

Cash & ST Invst.

$322.93M

Total Debt

$241.29M

Axsome Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$191.20M

+57.4%

Gross Profit

$176.48M

+58.0%

Gross Margin

92.30%

N/A

Market Cap

$11.14B

N/A

Market Cap/Employee

$15.65M

N/A

Employees

712

N/A

Net Income

$64.54M

-8.6%

EBITDA

$61.08M

-11.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$88.40M

-1.4%

Accounts Receivable

$251.06M

+55.6%

Inventory

$31.52M

+93.1%

Long Term Debt

$146.08M

-30.1%

Short Term Debt

$70.63M

+3011.4%

Return on Assets

-26.39%

N/A

Return on Invested Capital

-64.00%

N/A

Free Cash Flow

$20.82M

+52.4%

Operating Cash Flow

$20.70M

+52.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ARWRArrowhead Pharmaceuticals, Inc.

ARWRArrowhead Pharmaceuticals, Inc.$79.04+1.67%

CYTKCytokinetics, Incorporated

CYTKCytokinetics, Incorporated$74.81+0.34%

JAZZJazz Pharmaceuticals plc

JAZZJazz Pharmaceuticals plc$227.84+1.89%

ABVXAbivax S.A.

ABVXAbivax S.A.$121.39-0.61%

PCVXVaxcyte, Inc.

PCVXVaxcyte, Inc.$54.03+0.07%

NUVLNuvalent, Inc.

NUVLNuvalent, Inc.$102.54-1.92%

MTSRMetsera, Inc.

MTSRMetsera, Inc.$70.50-0.35%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.96-0.05%

NOKNokia

NOKNokia$13.17-0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.96-0.03%

POETPoet Technologies

POETPoet Technologies$13.73-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$43.31+0.03%

IRENIren

IRENIren$56.56+0.03%

MUMicron Technology

MUMicron Technology$766.58-0.04%

Questions About AXSM

What is the current price of Axsome Therapeutics?

Axsome Therapeutics is trading at $224.03 per share.

What is the 52-week range for Axsome Therapeutics?

Over the past 52 weeks, Axsome Therapeutics has traded between $96.09 and $234.29.

How much debt does Axsome Therapeutics have?

As of the most recent reporting period, Axsome Therapeutics reported total debt of $219.90M.

How much cash does Axsome Therapeutics have on hand?

Axsome Therapeutics reported $305.11M in cash and cash equivalents in its most recent financial results.

What is Axsome Therapeutics’s dividend yield?

Axsome Therapeutics does not currently have a dividend yield.

Axsome Therapeutics

Axsome Therapeutics Financials at a Glance

AXSM News

3 Stocks Poised to Disrupt the Healthcare Market by 2030

3 Overlooked Stocks Set to Soar in 2026

Why Did Axsome Therapeutics Stock Hit Another Record High Today?

Why Axsome Therapeutics Stock Jumped Over 20% in April

Best Biotech Stocks to Buy in 2026 and How to Invest in Them

Best Biotech ETFs to Buy in 2026

Is This Healthcare Stock a Millionaire Maker?

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain

AXSM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Axsome Therapeutics

AXSM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Axsome Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AXSM

What is the current price of Axsome Therapeutics?

What is the 52-week range for Axsome Therapeutics?

How much debt does Axsome Therapeutics have?

How much cash does Axsome Therapeutics have on hand?

What is Axsome Therapeutics’s dividend yield?

Premium Investing Services